Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$36.71

-1.61 (-4.20%)

16:23
11/06/18
11/06
16:23
11/06/18
16:23

Myriad Genetics sees FY19 adj. EPS $1.70-$1.75, consensus $1.72

Sees FY19 revenue $855M-$865M, consensus $887.98M.

  • 06

    Nov

  • 06

    Nov

  • 14

    Nov

MYGN Myriad Genetics
$36.71

-1.61 (-4.20%)

10/10/18
PIPR
10/10/18
UPGRADE
Target $53
PIPR
Overweight
Myriad Genetics upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk upgraded Myriad Genetics to Overweight and raised his price target for the shares to $53 from $38. After updating his reimbursement model for Myriad's Prolaris, Vectra, and GeneSight, the analyst believes the company has $9 of earnings per share power. Quirk now has increased confidence in Myriad's ability to beat Street expectations and admits he's been wrong on the shares.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $53
PIPR
Overweight
Myriad Genetics should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst William Quirk notes that Myriad Genetics' shares are off about 15% on two items, neither of which he believes will have a lasting effect on the company's business. First is an FDA safety communication about genetics tests used to predict drug response, he points out, adding that the letter "has teeth," but likely for consumer-oriented tests. The second is the 23&Me approval for a consumer-based pharmacogenomics test, which could certainly open up more testing, but within the consumer-driven, not physician-driven channel, he argues. Accordingly, Quirk recommends buying shares on the pullback, and reiterates an Overweight rating and $53 price target on the stock.
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Myriad Genetics shares defended at Morgan Stanley
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Overweight
Morgan Stanley says Myriad selloff on 23andMe approval a buying opportunity
Morgan Stanley analyst Steve Beuchaw said today's move lower in shares of Myriad Genetics "reflects confusion" on the regulatory backdrop for enetic tests and he believes the fact that 23andMe received an FDA approval yesterday for a consumer-facing pharmacogenetic screen is actually a positive for Myriad. Direct-to-consumer tests are not a substitute for clinical lab tests, as noted by the FDA, said Beuchaw, who believes uptake of consumer genomic tests, including their promotion by 23andMe, is a tailwind for Myriad and the category. He views the pullback as a buying opportunity and keeps an Overweight rating on Myriad Genetics shares.

TODAY'S FREE FLY STORIES

13:25
11/12/18
11/12
13:25
11/12/18
13:25
Conference/Events
Cowen integrated oil analyst to hold an analyst/industry conference call »

Integrated Oil, Refining…

SPY

SPDR S&P 500 ETF Trust

$273.42

-4.5 (-1.62%)

, SPX

S&P 500

$0.00

(0.00%)

13:23
11/12/18
11/12
13:23
11/12/18
13:23
General news
Trump 'hopes' Saudi Arabia, OPEC will not cut oil production »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$273.42

-4.5 (-1.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$141.20

-3.75 (-2.59%)

13:20
11/12/18
11/12
13:20
11/12/18
13:20
Hot Stocks
Facebook experiencing service issues »

Visiting Facebook.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

F

Ford

$9.53

0.15 (1.60%)

13:20
11/12/18
11/12
13:20
11/12/18
13:20
Options
Ford calls active as shares advance »

Ford calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/12/18
11/12
13:17
11/12/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.13

-0.21 (-0.55%)

13:16
11/12/18
11/12
13:16
11/12/18
13:16
Hot Stocks
Trump quotes FBN's Gasparino on cable association's 'big problems' with Comcast »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/12/18
11/12
13:16
11/12/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$117.77

0.25 (0.21%)

13:15
11/12/18
11/12
13:15
11/12/18
13:15
Options
PepsiCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

DISCA

Discovery

$32.83

-0.15 (-0.45%)

13:08
11/12/18
11/12
13:08
11/12/18
13:08
Recommendations
Discovery analyst commentary  »

Discovery acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBI

SPDR S&P BIOTECH

$77.95

-2.82 (-3.49%)

13:00
11/12/18
11/12
13:00
11/12/18
13:00
Options
Put spreads in SPDR S&P Biotech Fund as bearish positions are adjusted »

Put spreads in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.68

-0.12 (-1.76%)

12:59
11/12/18
11/12
12:59
11/12/18
12:59
Periodicals
Snap's VP of Content, Nick Bell, leaving today, Cheddar reports »

Snap's Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

LITE

Lumentum

$39.50

-16.45 (-29.40%)

, AAPL

Apple

$195.96

-8.35 (-4.09%)

12:57
11/12/18
11/12
12:57
11/12/18
12:57
Recommendations
Lumentum, Apple analyst commentary  »

Craig-Hallum cuts…

LITE

Lumentum

$39.50

-16.45 (-29.40%)

AAPL

Apple

$195.96

-8.35 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HD

Home Depot

$183.19

-2.85 (-1.53%)

, TSN

Tyson Foods

$61.79

-0.3 (-0.48%)

12:52
11/12/18
11/12
12:52
11/12/18
12:52
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$183.19

-2.85 (-1.53%)

TSN

Tyson Foods

$61.79

-0.3 (-0.48%)

AAP

Advance Auto Parts

$168.30

-2.88 (-1.68%)

ARMK

Aramark

$35.10

-0.49 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 03

    Mar

DF

Dean Foods

$6.10

0.12 (2.01%)

12:50
11/12/18
11/12
12:50
11/12/18
12:50
Options
Dean Foods draws call buying after volatility in shares last week »

Dean Foods draws call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AGR

Avangrid

$49.35

0.43 (0.88%)

, UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

12:45
11/12/18
11/12
12:45
11/12/18
12:45
Hot Stocks
Avangrid names Peter Church chief HR officer »

Avangrid (AGR) announced…

AGR

Avangrid

$49.35

0.43 (0.88%)

UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

RIG

Transocean

$10.17

-0.36 (-3.42%)

12:40
11/12/18
11/12
12:40
11/12/18
12:40
Options
Transocean puts active as shares slip »

Transocean puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$33.40

-0.59 (-1.74%)

12:35
11/12/18
11/12
12:35
11/12/18
12:35
Options
Blackstone put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

Athenahealth

$132.00

11.63 (9.66%)

12:26
11/12/18
11/12
12:26
11/12/18
12:26
Downgrade
Athenahealth rating change  »

Athenahealth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.90

0.205 (1.61%)

12:20
11/12/18
11/12
12:20
11/12/18
12:20
Options
Vote of confidence in US Oil Fund as shares tick higher »

Vote of confidence in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/12/18
11/12
12:17
11/12/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/12/18
11/12
12:16
11/12/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.80

-0.315 (-3.11%)

12:15
11/12/18
11/12
12:15
11/12/18
12:15
Options
Deutsche Bank put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.55

-1.18 (-1.80%)

12:13
11/12/18
11/12
12:13
11/12/18
12:13
Periodicals
Citi seeks bigger Paris office ahead of Brexit, FT reports »

Citigroup is eyeing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

CSLT

Castlight Health

$2.68

-0.01 (-0.37%)

12:11
11/12/18
11/12
12:11
11/12/18
12:11
Conference/Events
Castlight Health management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 27

    Nov

AAPL

Apple

$195.42

-8.89 (-4.35%)

, LITE

Lumentum

$38.36

-17.59 (-31.44%)

12:09
11/12/18
11/12
12:09
11/12/18
12:09
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AAPL

Apple

$195.42

-8.89 (-4.35%)

LITE

Lumentum

$38.36

-17.59 (-31.44%)

BABA

Alibaba

$142.11

-2.75 (-1.90%)

PCG

PG&E

$33.72

-6.17 (-15.47%)

EIX

Edison International

$55.03

-5.96 (-9.77%)

SAP

SAP

$101.49

-6.84 (-6.31%)

ATHN

Athenahealth

$132.04

11.67 (9.70%)

APTI

Apptio

$37.60

12.76 (51.37%)

OPK

Opko Health

$3.70

0.595 (19.16%)

BTI

British American Tobacco

$38.56

-3.18 (-7.62%)

GNC

GNC Holdings

$3.36

-0.87 (-20.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.